NCT05223387

Brief Summary

Anthogyr Axiom Tissue-Level implants and corresponding Multi-Unit abutments recently enriched the available product range for dental surgeons. This Post-Market Clinical Follow-Up study aims at confirming the safety and performance of these products. The comparison with similar Anthogyr Axiom Bone-level implants will provide additional information on the effect of platform-switching in bone level maintenance for single and two-piece design at the implant level.

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
2 countries

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Mar 2022Jul 2027

First Submitted

Initial submission to the registry

January 21, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 4, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

March 30, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 18, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 18, 2027

Expected
Last Updated

March 19, 2025

Status Verified

March 1, 2025

Enrollment Period

3.3 years

First QC Date

January 21, 2022

Last Update Submit

March 17, 2025

Conditions

Keywords

Anthogyrdentalimplant

Outcome Measures

Primary Outcomes (1)

  • Marginal Bone Level Change

    Change in crestal bone level measured by analysis of standardized peri-apical xrays \[mm\].

    6 months,12 months, and 3 years after loading

Secondary Outcomes (3)

  • Implant survival

    6 months,12 months, and 3 years after loading

  • Prosthesis Survival

    6 months,12 months, and 3 years after prosthesis placement

  • 14 item Oral Health Impact Profile (OHIP-14)

    screening visit, 6, 12 months and 3 years after loading

Other Outcomes (2)

  • Adverse Events

    3 years after inclusion

  • Device Deficiencies

    3 years after inclusion

Study Arms (2)

Study Group

EXPERIMENTAL

Anthogyr Axiom TL REG and corresponding Multi-Unit abutments

Device: Axiom TL REG

Control Group

ACTIVE COMPARATOR

Anthogyr Axiom BL REG and corresponding Multi-Unit abutment

Device: Axiom BL REG

Interventions

Anthogyr AXIOM TL Reg will be placed in healed bone crests in the mandible or maxilla for multiple teeth replacement, followed by a provisional prosthesis immediately loaded, if the patient needs a provisional. In each case, the MU abutment will be placed immediately after implant placement. Multi-Unit abutments are used to fix the prosthesis

Also known as: Multi-Unit abutment
Study Group

Axiom BL Reg implants will be placed in healed bone crests in the mandible or maxilla for multiple teeth replacement, followed by a provisional prosthesis immediately loaded, if the patient needs a provisional. In each case, the MU abutment will be placed immediately after implant placement. Multi-Unit abutments are used to fix the prosthesis

Also known as: Multi-Unit abutment
Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must have voluntarily signed the Informed Consent Form before any study related procedures are performed, are willing and able to attend scheduled follow-up visits and agree that the pseudonymized data are collected and analyzed.
  • Patients must be males or females who are a minimum of 18 years of age.
  • Patients with a minimum of 4 weeks history of edentulism in the study area, in need of a multiple teeth replacement with dental implants
  • Patients with complete soft tissue coverage of the socket at implant placement

You may not qualify if:

  • Uncontrolled systemic disease that would interfere with dental implant therapy (e.g. uncontrolled diabetes)
  • Any contraindications for oral surgical procedures
  • History of local irradiation therapy in the head / neck area
  • Patients who are currently heavy smokers (defined \>10 cigarettes per day or \>1 cigar per day), or have ≥ 20 pack years who use chewing tobacco
  • Medical conditions requiring chronic high dose steroid therapy or high dose anti-resorptive treatment
  • Subjects who have undergone administration of any investigational device within 30 days of enrolment in the study
  • Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability
  • Cognitive impairment that would interfere with the ability to perform adequate oral hygiene (assessed by Ottawa 3DY scale)
  • Patients with chronic pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Faculdade de Medicina Dentária da Universidade do Porto

Porto, Portugal

Location

Universidad International de Catalunya

Barcelona, Spain

Location

Universidad de Santiago de Compostela

Santiago de Compostela, Spain

Location

MeSH Terms

Conditions

Mouth, Edentulous

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesTooth Diseases

Study Officials

  • Juan Blanco Carrión, Pr.Dr.

    Universidad de Santiago de Compostela

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2022

First Posted

February 4, 2022

Study Start

March 30, 2022

Primary Completion

July 18, 2025

Study Completion (Estimated)

July 18, 2027

Last Updated

March 19, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations